Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Am J Trop Med Hyg ; 34(3): 633-47, 1985 May.
Artigo em Inglês | MEDLINE | ID: mdl-4003672

RESUMO

In November 1982, a U.S. Peace Corps volunteer in Kenya completed pre-exposure rabies prophylaxis with a standard 3 dose intradermal (ID) series of human diploid cell rabies vaccine (HDCV). In May 1983, she was bitten by a dog and died of rabies 3 months later. An initial investigation revealed that the patient, as well as 9 of 11 others immunized at the same time, had no rabies antibody titers (less than 1:5). We therefore instituted investigations into the immunogenicity of pre-exposure HDCV both in the United States and in developing countries. A serosurvey revealed unexpectedly low rabies titers in both Peace Corps volunteers and others immunized in developing countries. Antibody titers measured 2-3 weeks after ID immunization were compared in 9 groups totaling 271 persons in the United States and Kenya. There was no statistically significant difference in antibody titers in the 6 U.S. groups immunized from 1980-1984 (P greater than 0.15); however, groups immunized in the United States had significantly higher titers than a group of Kenyan nationals (P less than or equal to 0.0001), and the Kenyans had significantly higher titers than 2 Peace Corps groups immunized in Kenya (P less than or equal to 0.0001). No single hypothesis proposed (laboratory error, vaccine potency, vaccination technique, or specific immune suppression) accounted for the observed differences. Although we cannot fully explain the poor response to HDCV, it is probably due to multiple factors. We conclude that persons immunized with ID pre-exposure HDCV in developing countries should have rabies antibody titers determined to ensure their seroconversion; for persons immunized in the United States, such titers need not be routinely determined.


Assuntos
Anticorpos Antivirais/análise , Países em Desenvolvimento , Imunização , Vacina Antirrábica/imunologia , Vírus da Raiva/imunologia , Raiva/imunologia , Adulto , Cloroquina/efeitos adversos , Combinação de Medicamentos/efeitos adversos , Feminino , Humanos , Tolerância Imunológica/efeitos dos fármacos , Quênia , Pirimetamina/efeitos adversos , Raiva/prevenção & controle , Vacina Antirrábica/administração & dosagem , Sulfadoxina/efeitos adversos , Estados Unidos
2.
J Fam Pract ; 9(3): 407-14, 1979 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-479772

RESUMO

The Homestyle Delivery Program, an alternative birth service at the University of California Davis Medical Center, Sacramento, is presented. The program was developed jointly by the departments of family practice, obstetrics, and pediatrics, in response to the needs and desires of patients and physicians to participate in a more natural family centered birthing process. A brief description of the program and data from the first 1 1/2 years of operation is given. This program, in contrast to many other alternative birthing programs, involves physicians in training; that is, residents in family practice and obstetrics who are being taught during their obstetrical training how to create and facilitate an intimate family oriented home-like birthing. Satisfaction with the program on the part of the participating families as well as physicians and program staff has been very high. Today, more families in this society are demanding this kind of alternative birthing experience; the Homestyle Delivery Program meets their needs and to data has demonstrated no increased risk to mother or infant.


Assuntos
Parto Obstétrico , Serviços de Assistência Domiciliar , California , Feminino , Hospitais Universitários , Humanos , Recém-Nascido , Internato e Residência , Unidade Hospitalar de Ginecologia e Obstetrícia/organização & administração , Educação de Pacientes como Assunto , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA